37 results
8-K
EX-99.2
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
11 Mar 24
Regulation FD Disclosure
8:01am
meetings ; the occurrence and timing of market engagement ; expectations regarding the time period over which our capital resources will be sufficient
DEF 14A
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
26 Apr 23
Definitive proxy
4:31pm
. In addition, the Board is kept informed by Company management of the Company’s shareholder engagement efforts.
Code of Business Conduct and Ethics
8-K
nyyiz6rq1eqb wcf
17 Jun 22
Changes in Registrant's Certifying Accountant
4:05pm
8-K
EX-10.8
rtq1iiiwza3b
11 Apr 22
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-10.7
6uvm0
11 Apr 22
Entry into a Material Definitive Agreement
4:40pm
DEFR14A
4gz19
4 Mar 22
Revised proxy
4:06pm
DEFA14A
uja3spp mx4
19 Jan 22
Additional proxy soliciting materials
12:00am